First to market. Imagine Eyes has introduced adaptive optics technology in medicine. With our rtx1™ product, doctors can examine cellular structures and track microscopic lesions that were previously invisible in the retina.
New medical insight. Medical centers that adopted the rtx1 have published over 100 peer-reviewed articles. Their investigations with the rtx1 revealed new insights into not only retinal pathologies, but also arterial hypertension, vascular inflammation and diabetes.
Leading edge. Imagine Eyes is now deploying the rtx1 through an international network of distributors. Meanwhile, our engineers keep developing tomorrow’s retinal imaging technology.